Astellas CEO Yasukawa On Gene Therapy Challenges, Deal Strategies

Keen Focus On Tech

 
• By Lisa Takagi
  
Astellas has a clinical hold on its candidate AT845 lifted by FDA recently
Astellas has a clinical hold on its candidate AT845 lifted by FDA recently • Source: Shutterstock

More from Gene Therapies

More from Advanced Therapies